
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ion Channels: New Actors Playing in Chemotherapeutic Resistance
Philippe Kischel, Alban Girault, Lise Rodat‐Despoix, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 376-376
Open Access | Times Cited: 63
Philippe Kischel, Alban Girault, Lise Rodat‐Despoix, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 376-376
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Beyond matrix stiffness: targeting force-induced cancer drug resistance
Maria Kalli, Matthew D. Poskus, Triantafyllos Stylianopoulos, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 937-954
Open Access | Times Cited: 53
Maria Kalli, Matthew D. Poskus, Triantafyllos Stylianopoulos, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 937-954
Open Access | Times Cited: 53
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Claudia Tanja Mierke
Cells (2024) Vol. 13, Iss. 1, pp. 96-96
Open Access | Times Cited: 33
Claudia Tanja Mierke
Cells (2024) Vol. 13, Iss. 1, pp. 96-96
Open Access | Times Cited: 33
Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
Alina L. Capatina, Dimitris Lagos, William J. Brackenbury
Reviews of physiology, biochemistry and pharmacology (2020), pp. 1-43
Open Access | Times Cited: 51
Alina L. Capatina, Dimitris Lagos, William J. Brackenbury
Reviews of physiology, biochemistry and pharmacology (2020), pp. 1-43
Open Access | Times Cited: 51
Voltage-Gated K+/Na+ Channels and Scorpion Venom Toxins in Cancer
Alexis Díaz-García, Diego Varela
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 46
Alexis Díaz-García, Diego Varela
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 46
CD95/Fas and metastatic disease: What does not kill you makes you stronger
Jean‐Philippe Guégan, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 121-131
Open Access | Times Cited: 42
Jean‐Philippe Guégan, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 121-131
Open Access | Times Cited: 42
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response
Katia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Katia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Scorpion Toxins and Ion Channels: Potential Applications in Cancer Therapy
Rosa Amalia Dueñas-Cuellar, Carlos José Correia de Santana, Ana Carolina Martins Magalhães, et al.
Toxins (2020) Vol. 12, Iss. 5, pp. 326-326
Open Access | Times Cited: 33
Rosa Amalia Dueñas-Cuellar, Carlos José Correia de Santana, Ana Carolina Martins Magalhães, et al.
Toxins (2020) Vol. 12, Iss. 5, pp. 326-326
Open Access | Times Cited: 33
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound
Iris E. Ertl, Ursula Lemberger, Dafina Ilijazi, et al.
European Urology (2022) Vol. 82, Iss. 3, pp. 261-270
Open Access | Times Cited: 19
Iris E. Ertl, Ursula Lemberger, Dafina Ilijazi, et al.
European Urology (2022) Vol. 82, Iss. 3, pp. 261-270
Open Access | Times Cited: 19
Cutting Off H+ Leaks on the Inner Mitochondrial Membrane: A Proton Modulation Approach to Selectively Eradicate Cancer Stem Cells
Min-Su Park, Kyoung Sunwoo, Yoon-Jae Kim, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 8, pp. 4647-4658
Closed Access | Times Cited: 12
Min-Su Park, Kyoung Sunwoo, Yoon-Jae Kim, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 8, pp. 4647-4658
Closed Access | Times Cited: 12
Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells
Luca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Luca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
OSMOTIC STRESS INFLUENCES MICROTUBULE DRUG RESPONSE VIA WNK1 KINASE SIGNALING
Ana Monfort‐Vengut, Natalia Sanz‐Gómez, Sandra Ballesteros-Sánchez, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101203-101203
Closed Access
Ana Monfort‐Vengut, Natalia Sanz‐Gómez, Sandra Ballesteros-Sánchez, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101203-101203
Closed Access
Reduced store operated calcium entry contributes to autophagy mediated escape of prostate cancer to oxaliplatin treatment
Dheeraj Kannancheri Puthooru, Maya Yassine, Dmitri Gordienko, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119953-119953
Closed Access
Dheeraj Kannancheri Puthooru, Maya Yassine, Dmitri Gordienko, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119953-119953
Closed Access
The Role οf Ion Channels in the Development and Progression of Prostate Cancer
Minas Sakellakis, Athanasios Chalkias
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 2, pp. 227-242
Open Access | Times Cited: 9
Minas Sakellakis, Athanasios Chalkias
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 2, pp. 227-242
Open Access | Times Cited: 9
Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
Kitti Intuyod, Chariya Hahnvajanawong, Porntip Pinlaor, et al.
Anticancer Research (2019) Vol. 39, Iss. 9, pp. 4837-4843
Open Access | Times Cited: 29
Kitti Intuyod, Chariya Hahnvajanawong, Porntip Pinlaor, et al.
Anticancer Research (2019) Vol. 39, Iss. 9, pp. 4837-4843
Open Access | Times Cited: 29
High Expression of TTYH3 Is Related to Poor Clinical Outcomes in Human Gastric Cancer
Subbroto Kumar Saha, Polash Kumar Biswas, Minchan Gil, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1762-1762
Open Access | Times Cited: 29
Subbroto Kumar Saha, Polash Kumar Biswas, Minchan Gil, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1762-1762
Open Access | Times Cited: 29
KCa channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)
Felix Glaser, Petra Hundehege, Etmar Bulk, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Felix Glaser, Petra Hundehege, Etmar Bulk, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma
Lu Ao, Yidan Shi, Yijuan Liu, et al.
Lung Cancer (2021) Vol. 158, pp. 29-39
Open Access | Times Cited: 21
Lu Ao, Yidan Shi, Yijuan Liu, et al.
Lung Cancer (2021) Vol. 158, pp. 29-39
Open Access | Times Cited: 21
The modulation of ion channels in cancer chemo-resistance
Jiayu Zhao, Mei Li, Jiao Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Jiayu Zhao, Mei Li, Jiao Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinoma
Shuai Guo, Liang Qiu, Yafei Chen, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114062-114062
Closed Access | Times Cited: 23
Shuai Guo, Liang Qiu, Yafei Chen, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114062-114062
Closed Access | Times Cited: 23
T-Type Calcium Channels: A Potential Novel Target in Melanoma
Carla Barceló, Pol Sisó, Óscar Maiques, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 391-391
Open Access | Times Cited: 22
Carla Barceló, Pol Sisó, Óscar Maiques, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 391-391
Open Access | Times Cited: 22
Targeting Kca3.1 Channels in Cancer
Luca Matteo Todesca, Sarah Maskri, Kathrin Brömmel, et al.
Cellular Physiology and Biochemistry (2021) Vol. 55, Iss. S3, pp. 131-144
Open Access | Times Cited: 18
Luca Matteo Todesca, Sarah Maskri, Kathrin Brömmel, et al.
Cellular Physiology and Biochemistry (2021) Vol. 55, Iss. S3, pp. 131-144
Open Access | Times Cited: 18
Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells
Agata Wawrzkiewicz–Jałowiecka, Anna Lalik, Agnieszka Łukasiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7942-7942
Open Access | Times Cited: 7
Agata Wawrzkiewicz–Jałowiecka, Anna Lalik, Agnieszka Łukasiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7942-7942
Open Access | Times Cited: 7
Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway
Hiba Abou Daya, Sana Kouba, Hakim Ouled‐Haddou, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2314-2314
Open Access | Times Cited: 17
Hiba Abou Daya, Sana Kouba, Hakim Ouled‐Haddou, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2314-2314
Open Access | Times Cited: 17
Ca2+‐activated K+ channel KCa1.1 as a therapeutic target to overcome chemoresistance in three‐dimensional sarcoma spheroid models
Susumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3769-3783
Open Access | Times Cited: 17
Susumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3769-3783
Open Access | Times Cited: 17
TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
Tsung-Ming Chen, Chih-Ming Huang, Ming‐Shou Hsieh, et al.
Aging (2022) Vol. 14, Iss. 12, pp. 5250-5270
Open Access | Times Cited: 12
Tsung-Ming Chen, Chih-Ming Huang, Ming‐Shou Hsieh, et al.
Aging (2022) Vol. 14, Iss. 12, pp. 5250-5270
Open Access | Times Cited: 12